Organization
Genentech, South San Francisco, United States
2 abstracts
Abstract
A MULTICENTER, OPEN-LABEL, LONG-TERM EXTENSION STUDY OF SUMMACTA AND BREVACTA TO EVALUATE SAFETY AND EFFICACY OF TOCILIZUMAB SC IN PATIENTS WITH MODERATE TO SEVERE RA Org: Altoona Center for Clinical Research, Duncansville, University of Nevada School of Medicine, Las Vegas, Clinical Research Center of Reading, Reading, Genentech, South San Francisco, United States,
Abstract
AN OPEN-LABEL STUDY OF THE SAFETY OF RITUXIMAB (RTX) IN COMBINATION WITH OTHER BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDS) IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS (RA) Org: Dartmouth Hitchcock Medical Center, Lebanon, Swedish Rheumatology Associates, Seattle, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States of America, Genentech, South San Francisco, United States,